Mode VC
New York

Deerfield

Deerfield, based in New York, backs Seed-stage life sciences and healthtech startups, with a specialist style and a latest fund over $600M, as seen in Boulevard Bio and Atlas Data Storage.

WebsitePortfolioPitch pageTeam page
Entry stageSeed
Check sizen/a
Leads roundsn/a
FocusLife sciences, Healthtech
Latest fundOver $600M closed
Investing team4 peopleNo activity since Sep

Who you would pitch at Deerfield

4 people on the investing team, 3 of them partners who can make the call. Partners are listed first.

Jim Flynn
Jim FlynnManaging Partner; investment and portfolio oversightHe previously worked at Furman Selz, Alpharma Inc., and Kidder, Peabody & Co.
Stephen Anastos
Stephen AnastosManaging Director, Healthcare Services; joined to focus on early and growth-stage healthcare technology and services investmentsHe holds a degree from Harvard University and has experience in digital health and technology.
Anne Daub
Anne DaubPartner, TherapeuticsShe previously held analyst and vice president roles at several investment firms and holds a graduate degree in Finance.
Frank Nestle, M.D.Partner and Chief Executive Officer, Deerfield Discovery and Development

Work here and something is wrong? Ask for a correction.

Check size not reported yet.

Bars: how many firms in the atlas report each band. Highlighted: this firm.

No recent activity since September 2026. Quiet does not mean closed.

Weekly count of activity updates. Activity is not a confirmed deal.

In their words

Deerfield ManagementDeerfield is an investment firm dedicated to advancing healthcare through investment, intelligence, and philanthropy. We work across the healthcare ecosystem, connecting deerfield.com
Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Alert me when Deerfield is active

One email when this firm shows new activity. Nothing else.

Firms like Deerfield

Acorn Bioventures$100K to $10M
Arkitekt VenturesCheck size not reported
Casdin CapitalCheck size not reported
Catalio Capital ManagementCheck size not reported
Companion FundCheck size not reported
Digitalis VenturesCheck size not reported

On these lists

Seed healthtech investors in New York47Seed life sciences investors in New York26Seed investors in United States2836Seed investors in New York347Seed healthtech investors287Seed life sciences investors186Seed investors3020

Questions

What stage does Deerfield invest in?

Deerfield reports entry at seed.

How much does Deerfield invest?

Deerfield has not reported a check size.

Does Deerfield lead rounds?

Deerfield has not reported a lead preference.

Who are the partners at Deerfield?

Jim Flynn (Managing Partner; investment and portfolio oversight), Stephen Anastos (Managing Director, Healthcare Services; joined to focus on early and growth-stage healthcare technology and services investments), Anne Daub (Partner, Therapeutics).

Is Deerfield active right now?

No recent activity since September 2026.

Work at Deerfield? Claim or correct this profile.